Confluence Discovery Technologies
Pre-clinicalAvoid Pitfalls Costly Delays Quality Research Partner from Idea to IND Our expert drug discovery scientists help meet milestones and expedite your timeline to reaching development candidate, Investigational New Drug (IND) and ultimately to market. Request Your Complimentary Consultation Now Full Service Drug Discovery Contract Research Organization (CRO) Confluence Discovery Technologies, Inc., an indirectly wholly owned subsidiary of Aclaris Therapeutics,…
About
Avoid Pitfalls Costly Delays Quality Research Partner from Idea to IND Our expert drug discovery scientists help meet milestones and expedite your timeline to reaching development candidate, Investigational New Drug (IND) and ultimately to market. Request Your Complimentary Consultation Now Full Service Drug Discovery Contract Research Organization (CRO) Confluence Discovery Technologies, Inc., an indirectly wholly owned subsidiary of Aclaris Therapeutics,…
Funding History
1Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile